Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -12.11%12.97M | 4.51%16.41M | 4.51%16.41M | -27.84%8.55M | -34.13%9.45M | 1,418.82%14.76M | 1,449.96%15.7M | 1,449.96%15.7M | 1,043.59%11.85M | 1,254.43%14.35M |
| -Cash and cash equivalents | -12.94%12.68M | 3.83%16.27M | 3.83%16.27M | -29.48%8.32M | -36.39%9.1M | 1,414.86%14.57M | 1,446.51%15.67M | 1,446.51%15.67M | 1,038.77%11.8M | 1,249.71%14.3M |
| -Short term investments | 51.32%287.5K | 307.14%142.5K | 307.14%142.5K | 360.00%230K | 610.00%355K | 1,800.00%190K | --35K | --35K | --50K | --50K |
| Receivables | 119.80%721.2K | 16.15%656.3K | 16.15%656.3K | 112.08%707.4K | 969.13%639.75K | 2,729.36%328.12K | 16,263.19%565.02K | 16,263.19%565.02K | 20,263.37%333.55K | 508.36%59.84K |
| -Accounts receivable | 119.80%721.2K | 16.15%656.3K | 16.15%656.3K | 112.08%707.4K | 969.13%639.75K | 2,729.36%328.12K | 16,263.19%565.02K | 16,263.19%565.02K | 20,263.37%333.55K | 508.36%59.84K |
| Prepaid assets | -87.33%36.28K | -88.76%57.87K | -88.76%57.87K | -95.22%34.55K | -91.14%54.68K | 3,203.61%286.46K | 6,457.45%514.63K | 6,457.45%514.63K | --722.37K | 29,731.06%617.5K |
| Total current assets | -10.70%13.73M | 2.04%17.12M | 2.04%17.12M | -27.99%9.29M | -32.48%10.15M | 1,449.74%15.37M | 1,538.27%16.78M | 1,538.27%16.78M | 1,143.53%12.91M | 1,302.59%15.03M |
| Non current assets | ||||||||||
| Net PPE | 122.83%26.7M | 113.69%22.22M | 113.69%22.22M | 149.89%19.7M | 207.19%18.86M | 179.66%11.98M | 143.42%10.4M | 143.42%10.4M | 82.24%7.88M | 43.87%6.14M |
| Total non current assets | 122.83%26.7M | 113.69%22.22M | 113.69%22.22M | 149.89%19.7M | 207.19%18.86M | 179.66%11.98M | 143.42%10.4M | 143.42%10.4M | 82.24%7.88M | 43.87%6.14M |
| Total assets | 47.78%40.42M | 44.76%39.35M | 44.76%39.35M | 39.47%29M | 37.04%29.01M | 418.47%27.35M | 413.15%27.18M | 413.15%27.18M | 287.57%20.79M | 296.44%21.17M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 9.99%1.42M | -18.26%817.15K | -18.26%817.15K | 153.38%774.31K | 171.31%303.36K | 1,907.73%1.29M | 1,418.79%999.76K | 1,418.79%999.76K | 385.98%305.59K | 87.65%111.81K |
| -accounts payable | 9.99%1.42M | -18.26%817.15K | -18.26%817.15K | 153.38%774.31K | 171.31%303.36K | 1,907.73%1.29M | 1,418.79%999.76K | 1,418.79%999.76K | 385.98%305.59K | 87.65%111.81K |
| Current accrued expenses | 1,270.11%723.23K | -69.77%35.94K | -69.77%35.94K | -46.37%52.79K | -77.01%48.16K | 34.45%52.79K | 197.34%118.91K | 197.34%118.91K | 452.02%98.43K | 590.80%209.53K |
| Other current liabilities | 4.62%2.29M | 61.23%3.85M | 61.23%3.85M | 68.05%1.58M | 57.10%1.71M | 2,670.50%2.19M | 2,857.68%2.39M | 2,857.68%2.39M | 1,030.55%940.5K | 1,167.57%1.09M |
| Current liabilities | 25.50%4.43M | 34.11%4.7M | 34.11%4.7M | 79.07%2.41M | 46.21%2.06M | 1,835.06%3.53M | 1,779.17%3.5M | 1,779.17%3.5M | 720.32%1.34M | 701.42%1.41M |
| Non current liabilities | ||||||||||
| Non current deferred liabilities | 114.02%2.37M | 114.02%2.37M | 114.02%2.37M | 108.52%1.11M | 108.52%1.11M | 108.52%1.11M | 108.52%1.11M | 108.52%1.11M | 118.03%532K | 118.03%532K |
| Total non current liabilities | 114.02%2.37M | 114.02%2.37M | 114.02%2.37M | 108.52%1.11M | 108.52%1.11M | 108.52%1.11M | 108.52%1.11M | 108.52%1.11M | 118.03%532K | 118.03%532K |
| Total liabilities | 46.66%6.81M | 53.32%7.07M | 53.32%7.07M | 87.42%3.52M | 63.30%3.17M | 549.50%4.64M | 542.11%4.61M | 542.11%4.61M | 360.04%1.88M | 362.15%1.94M |
| Shareholders'equity | ||||||||||
| Share capital | 45.37%37.06M | 45.29%37.04M | 45.29%37.04M | 41.97%29.07M | 39.25%28.35M | 353.45%25.5M | 353.45%25.5M | 353.45%25.5M | 264.16%20.47M | 266.11%20.36M |
| -common stock | 45.37%37.06M | 45.29%37.04M | 45.29%37.04M | 41.97%29.07M | 39.25%28.35M | 353.45%25.5M | 353.45%25.5M | 353.45%25.5M | 264.16%20.47M | 266.11%20.36M |
| Retained earnings | -21.65%-4.84M | -67.95%-6.15M | -67.95%-6.15M | -103.98%-4.96M | -128.37%-3.89M | -146.66%-3.98M | -144.59%-3.66M | -144.59%-3.66M | -99.45%-2.43M | -37.18%-1.7M |
| Gains losses not affecting retained earnings | 21.34%1.13M | 139.91%1.11M | 139.91%1.11M | 59.16%1.1M | 182.84%1.11M | 87.69%929.21K | 18.10%462.07K | 18.10%462.07K | 76.65%691.11K | -10.66%391.24K |
| Other equity interest | 0.00%269.35K | 0.00%269.35K | 0.00%269.35K | 50.51%269.35K | 50.51%269.35K | 368.01%269.35K | 342.52%269.35K | 342.52%269.35K | 10.85%178.95K | 10.85%178.95K |
| Total stockholders'equity | 48.01%33.62M | 43.01%32.27M | 43.01%32.27M | 34.71%25.48M | 34.39%25.84M | 397.95%22.71M | 392.91%22.57M | 392.91%22.57M | 281.61%18.91M | 290.84%19.23M |
| Total equity | 48.01%33.62M | 43.01%32.27M | 43.01%32.27M | 34.71%25.48M | 34.39%25.84M | 397.95%22.71M | 392.91%22.57M | 392.91%22.57M | 281.61%18.91M | 290.84%19.23M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.